Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer

被引:20
|
作者
Ahyai, Sascha A. [1 ]
Zacharias, Mario [1 ]
Isbarn, Hendrik [1 ]
Steuber, Thomas [2 ]
Eichelberg, Christian [1 ]
Koellermann, Jens [3 ]
Fisch, Margit [1 ]
Karakiewicz, Pierre I. [4 ]
Huland, Hartwig [2 ]
Graefen, Markus [2 ]
Chun, Felix K. -H. [1 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Martini Clin, Prostate Canc Ctr, D-20246 Hamburg, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Inst Pathol, D-20246 Hamburg, Germany
[4] Univ Montreal, Canc Prognost & Hlth Outcomes Unit, Montreal, PQ, Canada
关键词
prostate cancer; tumour volume; biochemical recurrence; surgical margin; surgical volume; radical prostatectomy; RADICAL RETROPUBIC PROSTATECTOMY; TUMOR VOLUME; BIOCHEMICAL RECURRENCE; PROGRESSION; PREDICTORS; SPECIMENS; IMPACT; STAGE; MEN; EXTENSION;
D O I
10.1111/j.1464-410X.2009.09162.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To identify risk factors of a positive surgical margin (PSM) and the significance of a PSM after radical prostatectomy (RP) on biochemical recurrence (BCR) in exclusively pathologically confirmed organ-confined (OC) prostate cancer, as despite an excellent prognosis after RP, some patients with pathologically confirmed OC disease have BCR, and the prognostic significance of a PSM in these men remains unclear. PATIENTS AND METHODS We assessed 932 men with pathologically OC disease who were treated with RP by nine different surgeons between 1992 and 2004. The prognostic significance of clinical and pathological variables, including tumour volume (TV) and percentage of high-grade TV (%HGTV) were assessed. Logistic and Cox regression models were fitted to identify risk factors of a PSM and BCR. BCR was defined as a prostate-specific antigen (PSA) level of 0.1 ng/mL and increasing after an undetectable PSA level. RESULTS The total PSM rate was 12.9% (120 men); the mean TV (P < 0.001), but not %HGTV (P = 0.2) was significantly higher in patients with PSM. TV, nerve-sparing RP technique and surgical volume were independent risk factors for a PSM (P = 0.03). After a median follow-up of 35 months the overall BCR rate was 8.8% (82 men). Patients with a PSM had significantly higher BCR rates (21.7% vs 6.9%; P < 0.001). In univariable analysis, a high %HGTV (70.4%) was the most informative risk factor of BCR, followed by RP Gleason score (65.8%) and PSM (65.7%). Removal of PSM from a multivariable Cox model decreased the accuracy by 12.1% (P < 0.001). CONCLUSIONS Our findings show that in OC prostate cancer, the risk of a PSM depends on TV, surgical technique and surgical volume. PSM is a significant risk factor for BCR. However, only 20% men with OC disease and a PSM develop BCR; conversely, 80% of men are cured despite a PSM. Therefore, adjuvant therapy must be considered, with caution to avoid unnecessary overtreatment.
引用
收藏
页码:478 / 483
页数:6
相关论文
共 50 条
  • [21] Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence
    Goolam A.S.
    la Rosa A.H.-D.
    Manoharan M.
    Indian Journal of Surgical Oncology, 2018, 9 (2) : 225 - 231
  • [22] Prognostic significance of percent positive biopsies in clinically organ-confined prostate cancer treated with permanent prostate brachytherapy with or without supplemental external-beam radiation
    Merrick, GS
    Butler, WM
    Wallner, KE
    Galbreath, RW
    Lief, JH
    Adamovich, E
    CANCER JOURNAL, 2004, 10 (01): : 54 - 60
  • [23] Does the Distance of the Tumor from the Surgical Margin Affect Biochemical Recurrence in Patients with Pathological Organ-Confined Prostate Cancer?
    Ozbek, Ayse
    Ozbek, Ridvan
    Duvarci, Mehmet
    Kandemir, Olcay
    TURKISH JOURNAL OF PATHOLOGY, 2021, 37 (03) : 233 - 238
  • [24] Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer
    Salomon, L
    Anastasiadis, AG
    Levrel, O
    Katz, R
    Saint, F
    de la Taille, A
    Cicco, A
    Vordos, D
    Hoznek, A
    Chopin, D
    Abbou, CC
    UROLOGY, 2003, 61 (02) : 386 - 390
  • [25] Stereotactic body radiotherapy for organ-confined prostate cancer
    Alan J Katz
    Michael Santoro
    Richard Ashley
    Ferdinand Diblasio
    Matthew Witten
    BMC Urology, 10
  • [26] Role of lymphadenectomy in clinically organ-confined prostate cancer
    Dhar, Nivedita Bhatta
    Burkhard, Fiona C.
    Studer, Urs E.
    WORLD JOURNAL OF UROLOGY, 2007, 25 (01) : 39 - 44
  • [27] Status of cryotherapy in the treatment of organ-confined prostate cancer
    Sommer, F
    Derakhshani, P
    Zumbé, J
    Engelmann, U
    UROLOGE A, 2001, 40 (03): : 185 - 190
  • [28] Role of lymphadenectomy in clinically organ-confined prostate cancer
    Nivedita Bhatta Dhar
    Fiona C. Burkhard
    Urs E. Studer
    World Journal of Urology, 2007, 25 : 39 - 44
  • [29] Stereotactic body radiotherapy for organ-confined prostate cancer
    Meier, Robert
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (04) : 320 - 332
  • [30] Stereotactic body radiotherapy for organ-confined prostate cancer
    Katz, Alan J.
    Santoro, Michael
    Ashley, Richard
    Diblasio, Ferdinand
    Witten, Matthew
    BMC UROLOGY, 2010, 10